Table 1.
Overview of the clinical data of the examined patients (P: probe). The age, gender, the time span of symptoms before diagnosis, the setting: primary or recurrent tumor, the time span, till a relapse was diagnosed, as well as isocitrate dehydrogenase (IDH), O(6)-methylguanine-DNA methyltransferase (MGMT) promoter and 1p19q status was regarded. Two patients were included twice with primary and recurrent tumor, respectively (P11primary = P29recurrence; P06primary = P35recurrence).
| Symbol of Probe (P) | Age (Years) | Gender (Female ♀; Male ♂) | Symptoms Before Diagnosis (Days) | Primary Versus Recurrence | Time to Relapse (Months) | IDH Status | MGMT Status | 1p19q Status |
|---|---|---|---|---|---|---|---|---|
| P01 | 50 | ♂ | 3 | recurrence | 6 | wild-type | not methylated | co-deletion |
| P02 | 52 | ♂ | 28 | recurrence | 13 | wild-type | not methylated | no co-deletion |
| P04 | 43 | ♀ | 11 | primary | wild-type | methylated | no co-deletion | |
| P05 | 66 | ♂ | 3 | primary | wild-type | methylated | no co-deletion | |
| P06 | 78 | ♂ | 1 | primary | wild-type | methylated | no co-deletion | |
| P07 | 62 | ♂ | 3 | primary | wild-type | not methylated | no co-deletion | |
| P11 | 63 | ♀ | 0 | primary | wild-type | methylated | no co-deletion | |
| P12 | 71 | ♂ | 3 | primary | wild-type | methylated | no co-deletion | |
| P15 | 59 | ♂ | 3 | primary | wild-type | methylated | no co-deletion | |
| P16 | 78 | ♂ | 3 | primary | wild-type | not methylated | co-deletion | |
| P19 | 73 | ♂ | 60 | recurrence | 3 | wild-type | not methylated | no co-deletion |
| P21 | 56 | ♂ | 0 | primary | wild-type | methylated | no co-deletion | |
| P22 | 78 | ♂ | 2 | primary | wild-type | not methylated | no co-deletion | |
| P23 | 81 | ♀ | 180 | primary | wild-type | methylated | no co-deletion | |
| P24 | 57 | ♀ | 14 | primary | wild-type | methylated | no co-deletion | |
| P26 | 56 | ♂ | 180 | primary | wild-type | not methylated | not measured | |
| P27 | 52 | ♀ | 0 | recurrence | 17 | wild-type | methylated | no co-deletion |
| P28 | 79 | ♂ | 0 | primary | wild-type | methylated | not measured | |
| P29 | 63 | ♀ | 0 | recurrence | 3 | wild-type | methylated | no co-deletion |
| P30 | 63 | ♀ | 14 | primary | wild-type | unclear | not measured | |
| P34 | 63 | ♂ | 30 | primary | wild-type | methylated | not measured | |
| P35 | 79 | ♂ | 0 | recurrence | 15 | wild-type | methylated | no co-deletion |
| P36 | 74 | ♂ | 21 | primary | wild-type | not methylated | not measured | |
| P41 | 69 | ♀ | 60 | primary | wild-type | not methylated | not measured | |
| P42 | 71 | ♂ | 30 | primary | wild-type | methylated | not measured | |
| P43 | 58 | ♀ | 2 | primary | wild-type | not methylated | not measured | |
| P44 | 75 | ♀ | 0 | primary | wild-type | methylated | not measured |